Name: 5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference
Start: 2024-03-07
End: 2024-03-08
Location: Park Plaza Victoria London by Radisson, 239 Vauxhall Bridge Rd, Pimlico, London SW1V 1EQ, UK

CONFERENCE AGENDA

Registration	08:15 - 08:50
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening Remarks from the Chairperson	08:55 - 09:00
BIOMARKER DRUG DISCOVERY AND ASSAY VALIDATION
Keynote Presentation - ICT01, an anti-BTN3A mAb activating Vg9Vd2 cells Emmanuel Valentin, Vice President, Translational Medicine, Imcheck Therapeutics	09:00 - 09:30
Biomarker assay development and validation for cancer treatment Nathalie Steinhoff, Scientist, Cancer Immunotherapy, Numab Therapeutics AG Valerie Balme, Associate Director, Business Development, Veracyte	09:30 - 10:00
Enhanced Biomarker Discovery and Validation Using TMT® Proteomics Ian Pike, Chief Scientific Officer, Proteome Sciences PLC	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
Transforming Oncology with Predicine’s Liquid Biopsy Solutions Dr. Pan Du, Co-founder, president and CTO , Predicine	11:15 - 11:45
Combination Strategies for Personalised Cancer Therapy Sreejith Raveendran, Assistant Professor, Teesside University	11:45 - 12:15
Sample quality strategies, operations and patient centricity for biomarker analysis Debora Souza Da Costa, Senior Biosample Project Leader., Roche	12:15 - 12:45
Comprehensive Biomarker Strategies To Decipher The Tumor Microenvironment: From Tissue To High-Quality Spatial Insights Angela Vasaturo , Director of Scientific Affairs, Ultivue	12:45 - 13:15
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:15 - 14:15
ROLE OF BIOMARKERS IN PERSONALIZED MEDICINE
AI-driven analysis of morphological biomarkers for trials in haemato-oncology Daniel Royston, Consultant Clinical Advisor, Ground Truth Labs	14:15 - 14:45
AI in medicine - A paradigm shift for the diagnostic industry Thomas Gohl, Market Development Manager, Roche Diagnostics	14:45 - 15:15
Development of a colorectal cancer methylation panel and an actionable cancer mutation panel using targeted bisulfite next-generation sequencing Collin Hudzik, Scientist, EpigenDx	15:15 - 15:45
Afternoon Refreshments and Poster Presentation \| One-to-One Networking Meetings	15:45 - 16:30
Lifestyle and epigenetic changes Aparna Duggirala, Lecturer, Clinical Genetics, University of Derby	16:30 - 17:00
Back translation of preclinical models to humans Maria Dermit, Computational Biologist, Novo Nordisk	17:00 - 17:30
Closing Remarks from the Chairperson	17:30 - 18:00
Drinks Reception & Networking ....End of Day 1....	18:00 - 18:00

Registration	08:15 - 08:50
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening Remarks from the Chairperson	08:55 - 09:00
FROM BIOMARKERS TO CDx: STRATEGIES TO ACCELERATE CDx DEVELOPMENT AND COMMERCIALIZATION
Keynote Presentation : Use of biomarkers in clinical development to guide dosing regimen recommendation with the use of modelling and simulations models. Patrick Brossard, Director, Clinical Pharmacology, SOBI - Swedish Orphan Biovitrum AB	09:00 - 09:30
Tracking challenging pharmacodynamic biomarkers in normal tissue on Phase I clinical trials of new oncology agents Karen Swales, Senior Scientific Officer, Clinical PD Biomarker Group, The Institute of Cancer Research	09:30 - 10:00
With only 1/500 Biomarkers reaching the patient what can we do better? Christopher Peters, Clinical Senior Lecturer, Imperial College London	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
CLINICAL APPLICATIONS OF BIOMARKERS IN IMMUNOLOGY, NEUROLOGY, AND OTHER DISEASES
Anti-CD89 antibody for personalized treatment of IgA-mediated inflammatory disorders: Autoantigen-specific IgA, a biomarker with strong effector functions. Louis Boon, CSO and Board Member, JJP Biologics	11:15 - 11:45
The Lymphocyte Stability Index - a pan-cancer biomarker for response to immune checkpoint blockade Robert Watson, Clinical Lecturer, University of Oxford	11:45 - 12:15
Histone based liquid biopsies for the screening of cancer and cardiovascular diseases Manlio Vinciguerra, European Research Area (ERA) Chair, Medical University Varna & Faculty, Liverpool John Moores University, Liverpool	12:15 - 12:45
Generating pseudo-time progression of mucosal inflammation during Inflammatory Bowel Disease using spatially resolved multi-omics data Priyank Patel, Senior Scientist, Department of Immunology & Respiratory Discovery Research, Boehringer Ingelheim Pharmaceuticals, Inc	12:45 - 13:15
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:15 - 14:15
Panel Discussion: What are the biggest challenges faced in developing an assay: why and what have we learnt from it ? Patrick Brossard, Director, Clinical Pharmacology, SOBI - Swedish Orphan Biovitrum AB Christopher Peters, Clinical Senior Lecturer, Imperial College London Maria Dermit, Computational Biologist, Novo Nordisk Manlio Vinciguerra, European Research Area (ERA) Chair, Medical University Varna & Faculty, Liverpool John Moores University, Liverpool Fernando Oneissi Martinez Estrada, Senior Lecturer in Innate Immunology, University of Surrey	14:15 - 14:45
Closing Remarks from the Chairperson	14:45 - 14:50
END OF CONFERENCE	14:50 - 14:50